Drug recall
BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by…
FDA recall event 82676 · Class II · Pacifico National, Inc. dba AmEx Pharmacy
Key facts
| Event ID | 82676 |
|---|---|
| Recall numbers | D-1271-2019 |
| Recalling firm | Pacifico National, Inc. dba AmEx Pharmacy |
| Product type | Drugs |
| Products | BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 Lot:190212AB BUD:5/13/2019… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Defective Delivery System: difficult to express |
| Initiation date | Apr 19, 2019 |
| Report date | May 8, 2019 |
| Termination date | Feb 16, 2021 |
| City | Melbourne |
| State | FL |
| Country | United States |
| FEI number | 3012034698 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: